Three-dimensional (3D) culture systems have emerged as powerful tools to model tumor biology and bridge the gap between conventional two-dimensional (2D) assays and in vivo studies. Here, we evaluate a poly(ethylene glycol)-based hydrogel as a simplified yet functionally relevant platform for modeling premalignant lung adenocarcinoma using the A549 cell line. Cells cultured in hydrogels exhibited transcriptional profiles that more closely resembled xenograft tumors than conventional 2D monolayers. Pathway-level analysis and regression-based benchmarking revealed restoration of critical hallmark programs, including proliferation, immune signaling, developmental pathways, and stress response cascades. While the 3D model does not fully recapitulate the complexity of the tumor microenvironment, its chemically defined, tunable, and reproducible design offers an accessible, physiologically informative model of lung adenocarcinoma that restores key transcriptional and functional features lost in conventional culture systems.
Impact Statement
This research establishes a poly(ethylene glycol)-based 3D culture as a more translationally relevant lung cancer model than 2D systems and provides a general framework for benchmarking engineered tumor models against in vivo biology.
SiegelRL, KratzerTB, GiaquintoAN, et al.Cancer statistics, 2025. CA A Cancer J Clinicians2025;75(1):10–45; doi: 10.3322/caac.21871
2.
BrahmerJR, GovindanR, AndersRA, et al.The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC). J Immunotherapy Cancer2018;6(1):75; doi: 10.1186/s40425-018-0382-2
3.
ReckM, HeigenerDF, MokT, et al.Management of non-small-cell lung cancer: Recent developments. Lancet2013;382(9893):709–719; doi: 10.1016/S0140-6736(13)61502-0
4.
FordePM, EttingerDS. Targeted therapy for non-small-cell lung cancer: Past, present and future. Expert Rev Anticancer Ther2013;13(6):745–758; doi: 10.1586/era.13.47
5.
EttingerDS, WoodDE, AisnerDL, et al.Non–Small Cell Lung Cancer, Version 3.2022. NCCN Clinical Practice Guidelines in Oncology; 2022; doi: 10.6004/jnccn.2022.0025
6.
JensenC, TengY. Is it time to start transitioning from 2D to 3D cell culture? Front Mol Biosci2020;7; doi: 10.3389/fmolb.2020.00033
7.
BarretinaJ, CaponigroG, StranskyN, et al.The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature2012;483(7391):603–607; doi: 10.1038/nature11003
8.
HavertyPM, LinE, TanJ, et al.Reproducible pharmacogenomic profiling of cancer cell line panels. Nature2016;533(7603):333–337; doi: 10.1038/nature17987
9.
IorioF, KnijnenburgTA, VisDJ, et al.A landscape of pharmacogenomic interactions in cancer. Cell2016;166(3):740–754; doi: 10.1016/j.cell.2016.06.017
10.
GarnettMJ, EdelmanEJ, HeidornSJ, et al.Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature2012;483(7391):570–575; doi: 10.1038/nature11005
11.
DuvalK, GroverH, HanL-H, et al.Modeling physiological events in 2D vs. 3D cell culture. Physiology (Bethesda)2017;32(4):266–277; doi: 10.1152/physiol.00036.2016
12.
HabanjarO, Diab-AssafM, Caldefie-ChezetF, et al.3D cell culture systems: Tumor application, advantages, and disadvantages. Int J Mol Sci2021;22(22):12200; doi: 10.3390/ijms222212200
13.
EdmondsonR, BroglieJJ, AdcockAF, et al.Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol2014;12(4):207–218; doi: 10.1089/adt.2014.573
14.
DrapkinBJ, GeorgeJ, ChristensenCL, et al.Genomic and functional fidelity of small cell lung cancer patient-derived xenografts. Cancer Discov2018;8(5):600–615; doi: 10.1158/2159-8290.CD-17-0935
15.
SiolasD, HannonGJ. Patient-derived tumor xenografts: Transforming clinical samples into mouse models. Cancer Res2013;73(17):5315–5319; doi: 10.1158/0008-5472.CAN-13-1069
16.
CuencaRE, TakitaH, BankertR. Orthotopic engraftment of human lung tumours in SCID mice for the study of metastasis. Surg Oncol1996;5(2):85–91; doi: 10.1016/S0960-7404(96)80005-3
17.
FischbachC, ChenR, MatsumotoT, et al.Engineering tumors with 3D scaffolds. Nat Methods2007;4(10):855–860; doi: 10.1038/nmeth1085
18.
VellaN, FenechAG, Petroni MagriV. 3D cell culture models in research: Applications to lung cancer pharmacology. Front Pharmacol2024;15:1438067; doi: 10.3389/fphar.2024.1438067
TibbittMW, AnsethKS. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng2009;103(4):655–663; doi: 10.1002/bit.22361
23.
WangC, TongX, YangF. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels. Mol Pharm2014;11(7):2115–2125; doi: 10.1021/mp5000828
24.
GillBJ, GibbonsDL, RoudsariLC, et al.A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res2012;72(22):6013–6023; doi: 10.1158/0008-5472.CAN-12-0895
25.
NguyenR, WuH, PoundsS, et al.A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia. J Immunotherapy Cancer2019;7(1):81; doi: 10.1186/s40425-019-0564-6
26.
TemplesMN, AdjeiIM, NimocksPM, et al.Engineered three-dimensional tumor models to study natural killer cell suppression. ACS Biomater Sci Eng2020;6(7):4179–4199; doi: 10.1021/acsbiomaterials.0c00259
27.
RoudsariLC, JeffsSE, WestJL. Lung adenocarcinoma cell responses in a 3D in vitro tumor angiogenesis model correlate with metastatic capacity. ACS Biomater Sci Eng2018;4(2):368–377; doi: 10.1021/acsbiomaterials.7b00011
28.
Del BufaloF, ManzoT, HoyosV, et al.3D modeling of human cancer: A PEG-fibrin hydrogel system to study the role of tumor microenvironment and recapitulate the in vivo effect of oncolytic adenovirus. Biomaterials2016;84:76–85; doi: 10.1016/j.biomaterials.2016.01.030
29.
PradhanS, HassaniI, SeetoWJ, et al.PEG-fibrinogen hydrogels for three-dimensional breast cancer cell culture. J Biomed Mater Res A2017;105(1):236–252; doi: 10.1002/jbm.a.35899
30.
BrayLJ, BinnerM, FreudenbergU, et al.Hydrogel-based in vitro models of tumor angiogenesis. Methods Mol Biol2017;1612:39–63; doi: 10.1007/978-1-4939-7021-6_4
31.
TemplesMN, LightseyS, ConklinT, et al.3D chemotaxis chip for investigating natural killer cell migration mechanisms. bioRxiv2025; doi: 10.1101/2025.04.21.649825
32.
GamerithG, RainerJ, HuberJM, et al.3D-cultivation of NSCLC cell lines induce gene expression alterations of key cancer-associated pathways and mimic in-vivo conditions. Oncotarget2017;8(68):112647–112661; doi: 10.18632/oncotarget.22636
33.
DasP, NajafikhoshnooS, Tavares-NegreteJA, et al.An in-vivo-mimicking 3D lung cancer-on-a-chip model to study the effect of external stimulus on the progress and inhibition of cancer metastasis. Bioprinting2022;28:e00243; doi: 10.1016/j.bprint.2022.e00243
34.
ZouS, YeJ, WeiY, et al.Characterization of 3D-bioprinted in vitro lung cancer models using RNA-sequencing techniques. Bioengineering (Basel)2023;10(6):667; doi: 10.3390/bioengineering10060667
35.
DongY, QianS, WangX, et al.In situ tailored confining microenvironment for lung cancer spheroids. Mater Today Bio2025;31:101602; doi: 10.1016/j.mtbio.2025.101602
36.
ErtekinÖ, MonavariM, KrügerR, et al.3D hydrogel-based microcapsules as an in vitro model to study tumorigenicity, cell migration and drug resistance. Acta Biomater2022;142:208–220; doi: 10.1016/j.actbio.2022.02.010
37.
MishraDK, SakamotoJH, ThrallMJ, et al.Human lung cancer cells grown in an ex vivo 3D lung model produce matrix metalloproteinases not produced in 2D culture. PLoS One2012;7(9):e45308; doi: 10.1371/journal.pone.0045308
38.
WangM, LiW, Sanchez FloresR, et al.Bioprinted human lung cancer-mimics for tissue diagnostics applications. Tissue Eng Part A2024;30(11–12):270–279; doi: 10.1089/ten.tea.2023.0149
39.
XuZ, LiE, GuoZ, et al.Design and construction of a multi-organ microfluidic chip mimicking the in vivo microenvironment of lung cancer metastasis. ACS Appl Mater Interfaces2016;8(39):25840–25847; doi: 10.1021/acsami.6b08746
40.
TurturroMV, ChristensonMC, LarsonJC, et al.MMP-sensitive PEG diacrylate hydrogels with spatial variations in matrix properties stimulate directional vascular sprout formation. PLoS One2013;8(3):e58897; doi: 10.1371/journal.pone.0058897
41.
MannBK, GobinAS, TsaiAT, et al.Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: Synthetic ECM analogs for tissue engineering. Biomaterials2001;22(22):3045–3051; doi: 10.1016/S0142-9612(01)00051-5
42.
YangF, WilliamsCG, WangD-A, et al.The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials2005;26(30):5991–5998; doi: 10.1016/j.biomaterials.2005.03.018
43.
ZhuJ, TangC, Kottke-MarchantK, et al.Design and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptides. Bioconjugate Chem2009;20(2):333–339; doi: 10.1021/bc800441v
44.
HortonMA. The αvβ3 integrin “vitronectin receptor. The International Journal of Biochemistry & Cell Biology1997;29(5):721–725; doi: 10.1016/S1357-2725(96)00155-0
45.
RuoslahtiE. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol1996;12:697–715; doi: 10.1146/annurev.cellbio.12.1.697
46.
Marchi-ArtznerV, LorzB, HellererU, et al.Selective adhesion of endothelial cells to artificial membranes with a synthetic RGD-lipopeptide. Chemistry2001;7(5):1095–1101; doi: 10.1002/1521-3765(20010302)7:5%253C1095::AID-CHEM1095%253E3.0.CO;2-B
47.
ZuidemaJM, RivetCJ, GilbertRJ, et al.A protocol for rheological characterization of hydrogels for tissue engineering strategies. J Biomed Mater Res2014;102(5):1063–1073; doi: 10.1002/jbm.b.33088
48.
CornelisonRC, Gonzalez-RothiEJ, PorvasnikSL, et al.Injectable hydrogels of optimized acellular nerve for injection in the injured spinal cord. Biomed Mater2018;13(3):e034110; doi: 10.1088/1748-605X/aaab82
49.
RaoVV, VuMK, MaH, et al.Rescuing mesenchymal stem cell regenerative properties on hydrogel substrates post serial expansion. Bioeng Transl Med2019;4(1):51–60; doi: 10.1002/btm2.10104
50.
KloxinAM, BentonJA, AnsethKS. In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials2010;31(1):1–8; doi: 10.1016/j.biomaterials.2009.09.025
51.
AnsethKS, BowmanCN, Brannon-PeppasL. Mechanical properties of hydrogels and their experimental determination. Biomaterials1996;17(17):1647–1657; doi: 10.1016/0142-9612(96)87644-7
52.
AhearneM, YangY, El HajAJ, et al.Characterizing the viscoelastic properties of thin hydrogel-based constructs for tissue engineering applications. J R Soc Interface2005;2(5):455–463; doi: 10.1098/rsif.2005.0065
53.
RichbourgNR, PeppasNA. The swollen polymer network hypothesis: Quantitative models of hydrogel swelling, stiffness, and solute transport. Prog Polym Sci2020;105:101243; doi: 10.1016/j.progpolymsci.2020.101243
54.
RobinsonMD, McCarthyDJ, SmythGK. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics2010;26(1):139–140; doi: 10.1093/bioinformatics/btp616
55.
LawCW, ChenY, ShiW, et al.voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol2014;15(2):R29; doi: 10.1186/gb-2014-15-2-r29
56.
RitchieME, PhipsonB, WuD, et al.limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res2015;43(7):e47; doi: 10.1093/nar/gkv007
YuG, WangL-G, HanY, et al.clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS2012;16(5):284–287; doi: 10.1089/omi.2011.0118
60.
KorotkevichG, SukhovV, BudinN, et al.Fast gene set enrichment analysis. bioRxiv2021:e060012; doi: 10.1101/060012
61.
R Core Team. (2023. R A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna; References—Scientific Research Publishing. Available from: https://www.scirp.org/reference/referencespapers?referenceid=3582659 [Last accessed: September7, 2025].
62.
DengB, ZhaoZ, KongW, et al.Biological role of matrix stiffness in tumor growth and treatment. J Transl Med2022;20(1):540; doi: 10.1186/s12967-022-03768-y
63.
ShuklaVC, Higuita-CastroN, Nana-SinkamP, et al.Substrate stiffness modulates lung cancer cell migration but not epithelial to mesenchymal transition. J Biomed Mater Res A2016;104(5):1182–1193; doi: 10.1002/jbm.a.35655
64.
BoothAJ, HadleyR, CornettAM, et al.Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med2012;186(9):866–876; doi: 10.1164/rccm.201204-0754OC
65.
BerniakK, RybakP, BernasT, et al.Relationship between DNA damage response, initiated by camptothecin or oxidative stress, and DNA replication, analyzed by quantitative 3D image analysis. Cytometry A2013;83(10):913–924; doi: 10.1002/cyto.a.22327
66.
JanesMR, ZhangJ, LiL-S, et al.Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor. Cell2018;172(3):578–589.e17; doi: 10.1016/j.cell.2018.01.006
67.
LowyDR, CollinsFS. Aiming high—changing the trajectory for cancer. N Engl J Med2016;374(20):1901–1904; doi: 10.1056/NEJMp1600894
SunD, GaoW, HuH, et al.Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B2022;12(7):3049–3062; doi: 10.1016/j.apsb.2022.02.002
71.
BlombergR, SompelK, HauerC, et al.Hydrogel-embedded precision-cut lung slices model lung cancer premalignancy ex vivo. Adv Healthc Mater2024;13(4):e2302246; doi: 10.1002/adhm.202302246
72.
MengF, MeyerCM, JoungD, et al.3D bioprinted in vitro metastatic models via reconstruction of tumor microenvironments. Advanced Materials2019;31(10):1806899; doi: 10.1002/adma.201806899
73.
Guerrero-LópezP, Martín-PardillosA, Bonet-AletaJ, et al.2D versus 3D tumor-on-chip models to study the impact of tumor organization on metabolic patterns in vitro. Sci Rep2025;15(1):19506; doi: 10.1038/s41598-025-03504-8
74.
WangH-M, ZhangC-Y, PengK-C, et al.Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study. CR Med2023;4(2):100911; doi: 10.1016/j.xcrm.2022.100911
75.
HanahanD, WeinbergRA. Hallmarks of cancer: The next generation. Cell2011;144(5):646–674; doi: 10.1016/j.cell.2011.02.013
76.
KentLN, LeoneG. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer2019;19(6):326–338; doi: 10.1038/s41568-019-0143-7
77.
KumarM, AllisonDF, BaranovaNN, et al.NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells. PLoS One2013;8(7):e68597; doi: 10.1371/journal.pone.0068597
78.
SakumaY, YamazakiY, NakamuraY, et al.NF-κB signaling is activated and confers resistance to apoptosis in three-dimensionally cultured EGFR-mutant lung adenocarcinoma cells. Biochem Biophys Res Commun2012;423(4):667–671; doi: 10.1016/j.bbrc.2012.06.009
79.
OnoderaR, JimmaY, SuzukiA, et al.The regulation pathway of VEGF gene expression is different between 2D cells and 3D spheroids in human lung cancer cells. Biol Pharm Bull2023;46(4):608–613; doi: 10.1248/bpb.b22-00772
80.
MazieresJ, HeB, YouL, et al.Wnt signaling in lung cancer. Cancer Lett2005;222(1):1–10; doi: 10.1016/j.canlet.2004.08.040
81.
DostAFM, MoyeAL, VedaieM, et al.Organoids model transcriptional hallmarks of oncogenic KRAS activation in lung epithelial progenitor cells. Cell Stem Cell2020;27(4):663–678.e8; doi: 10.1016/j.stem.2020.07.022
82.
RiedlA, SchledererM, PudelkoK, et al.Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT–mTOR–S6K signaling and drug responses. J Cell Sci2017;130(1):203–218; doi: 10.1242/jcs.188102
83.
GazdarAF, GirardL, LockwoodWW, et al.Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst2010;102(17):1310–1321; doi: 10.1093/jnci/djq279
84.
BaldassiD, GaboldB, MerkelO. Air-liquid interface cultures of the healthy and diseased human respiratory tract: Promises, challenges and future directions. Adv Nanobiomed Res2021;1(6):2000111; doi: 10.1002/anbr.202000111
85.
GongF, YangY, WenL, et al.An overview of the role of mechanical stretching in the progression of lung cancer. Front Cell Dev Biol2021;9; doi: 10.3389/fcell.2021.781828
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
